ECTOSENSE
ActiveSummary
ECTOSENSE has been active since 2015 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €4.9m and a net result of €6.5m, of which €11.5m non-recurring income. Equity is growing by about 7.5% per year across the filed financial years. Its solvency ranks better than 39% of 3,374 sector peers (NACE 62, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Directors
Board 2
Statutory auditor 1
Not every act has been read: a resignation may still be missing
Mandate history
- Board
- Statutory auditor
- began earlier
| Name | Functions and periods |
|---|---|
| Michael James RIDER |
|
| James Robert O'Donnell |
|
| BDO Bedrijfsrevisoren bv |
|
| Bart Van Pee |
|
| David Brian PENDARVIS |
|
Owners and capital
Owners
1 ownerChain of control
- ResMed INCUS
- ECTOSENSE
Highest known parent: ResMed INC (United States). The sources do not say who stands above it.
Owners 1
- ResMed INCUSconsolidating parentconsolidates
According to the annual accounts to 30-06-2022 of ECTOSENSE and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.